Friday, November 13, 2026 Vol. I · No. 1
Tech · Via Ars Technica

Millions of Americans are not taking their GLP-1 drugs as prescribed

AT
Reported by Ars TechnicaUS · Published · 1h ago
Image: Ars Technica

Cost and access barriers are pushing people to modified use and unapproved versions.

This is a brief. The reporting belongs to Ars Technica — read the complete story, with full context and credits, at the source.

Read the full story at Ars Technica ↗

arstechnica.com

More from the Tech desk